Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients

Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies

(2015) Sabeena Sharma et al.   BIOMEDICINE & PHARMACOTHERAPY

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

(2015) Rajesh Pahwa et al.   MOVEMENT DISORDERS

Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease

(2014) Manuela Pilleri et al.   Expert Opinion On Drug Safety

Novel formulations and modes of delivery of levodopa

(2014) Werner Poewe et al.   MOVEMENT DISORDERS

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results

(2014) Hubert H. Fernandez et al.   MOVEMENT DISORDERS

Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries

(2014) Marlene C. Hechtner et al.   PARKINSONISM & RELATED DISORDERS

Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review

(2013) Jens Volkmann et al.   JOURNAL OF NEUROLOGY

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

(2013) C Warren Olanow et al.   LANCET NEUROLOGY

Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation

(2011) Mahmoud M. Iravani et al.   JOURNAL OF NEURAL TRANSMISSION

Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE-PD study

(2010) Fabrizio Stocchi et al.   ANNALS OF NEUROLOGY

Pharmacokinetic-Pharmacodynamic Modeling of Levodopa in Patients With Advanced Parkinson Disease

(2010) Urszula Adamiak et al.   CLINICAL NEUROPHARMACOLOGY

Pharmacokinetics of levodopa

(2010) Manuela Contin et al.   JOURNAL OF NEUROLOGY

Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled Trial

(2009) Frances M. Weaver   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pharmacokinetics and pharmacodynamics of levodopa

(2008) John G. Nutt   MOVEMENT DISORDERS

Basic Research on Dopamine in Parkinson’s Disease and the Discovery of the Nigrostriatal Dopamine Pathway: The View of an Eyewitness

(2008) Oleh Hornykiewicz   Neurodegenerative Diseases